Evidence map›Paper›PMID 40585672›Full record

ArticleCureus2025

Development of Schizophrenia in an Autistic Patient With a Rare Chromosome 8p23.1 Deletion.

Ambria M Pogue, Davin Agustines

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ambria M PogueMedicine, Western University of Health Sciences, Pomona, USA.
Davin AgustinesPsychiatry, Olive View-University of California Los Angeles Medical Center, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schizophrenia is a complex disorder influenced by a combination of genetic and non-genetic factors that contribute to its development. Individuals with early neurodevelopmental conditions, such as autism spectrum disorder (ASD), may be at a higher risk for the manifestation of a psychotic disorder later in life. This case describes a female in her mid-20s with a history of ASD, diagnosed in early childhood following delays in developmental milestones and significant academic challenges. Genetic evaluation at that time identified a chromosome 8p23.1 deletion, which was not observed in other family members, consistent with a de novo mutation. Despite having this diagnosis, the patient was able to graduate from high school while being in a mix of special education and partial mainstream programs. However, over the past year, she developed progressive psychotic symptoms characterized by persecutory delusions and behavioral dysregulation, resulting in psychiatric hospitalization and a subsequent diagnosis of schizophrenia. While it is unclear what caused these psychotic symptoms to come about, the neurodevelopmental delays that are attributed to the chromosome 8p23.1 deletion may play a role in not only the development of schizophrenia in this patient but also the severity. This case demonstrates the potential implications of neurodevelopmental and psychotic disorders and highlights the importance of long-term monitoring in individuals with multiple neuropsychiatric conditions.

Indexed as

autism spectrum disorderchromosomal deletionmental healthneuropsychiatric disordersschizophrenia

Identifiers

PMID40585672
PMCPMC12205931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.